Ribavirin pharmacokinetics and interleukin 28B plus cytochrome P450 27B1 single-nucleotide polymorphisms as predictors of response to pegylated interferon/ribavirin treatment in patients infected with hepatitis C virus genotype 1/4

Hepatology. 2011 Dec;54(6):2278-9. doi: 10.1002/hep.24636.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Female
  • Hepacivirus / genetics*
  • Hepatitis C, Chronic / drug therapy*
  • Hepatitis C, Chronic / virology*
  • Humans
  • Interleukins / genetics*
  • Male
  • Vitamin D Deficiency / genetics*

Substances

  • Interleukins